Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

Hepatology

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Am J Gastroenterol

Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E

doi: 10.14309/ajg.0000000000003493

Pancreas Diseases

Association between estimated plasma volume status and the risk of 30-day mortality in patients with severe acute pancreatitis: a retrospective study based on the MIMIC-IV database

BMC Gastroenterol

Zhang H, Li J, Wang D, Wang J, Duan L, Zhang J

doi: 10.1186/s12876-025-03895-y

Gastrointestinal Cancer

Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study

J Clin Oncol

Philip PA, Sahai V, Bahary N, Mahipal A, Kasi A, Rocha Lima CMS, Alistar AT, Oberstein PE, Golan T, Metges JP, Lacy J, Fountzilas C, Lopez CD, Ducreux M, Hammel P, Salem M, Bajor D, Benson AB, Luther S, Pardee T, Van Cutsem E

doi: 10.1200/JCO.23.02659

Hepatology

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study

Lancet Gastroenterol Hepatol

Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hernández JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Solé C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team

doi: 10.1016/S2468-1253(25)00006-8

Hepatitis

Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study

Lancet Gastroenterol Hepatol

Vincent JP, Ségéral O, Kania D, Borand L, Adoukara JP, Pivert A, Koné A, Tiendrebeogo ASE, Tall H, Schaeffer L, Vray M, Sanou AM, Njouom R, Cloherty G, Hashimoto N, Miura T, Sugiura W, Sovann S, Yang JS, Delvallez G, Lunel-Fabiani F, Tanaka Y, Shimakawa Y, HBcrAg-RDT Study Group

doi: 10.1016/S2468-1253(25)00015-9

Hepatology

Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis

Gastroenterology

Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y

doi: 10.1053/j.gastro.2024.10.035

Inflammatory Bowel Disease

Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study

Lancet Gastroenterol Hepatol

Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D

doi: 10.1016/S2468-1253(24)00319-4

Hepatology

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study

Lancet Gastroenterol Hepatol

Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M

doi: 10.1016/S2468-1253(24)00274-7

Inflammatory Bowel Disease

Non-Conventional Dysplasia in Patients with Inflammatory Bowel Disease and Colorectal Adenocarcinoma: A Case-Cohort Study

J Crohns Colitis

Urquhart SA, Pallipamu N, Voruganti HV, Baraskar B, Muddaloor P, Sethi AK, Redij R, Aedma K, Gopalakrishnan K, Poigai Arunachalam S, Burger KN, Mahoney DW, Kassmeyer BA, Lennon RJ, Kisiel JB, Coelho-Prabhu N

doi: 10.1093/ecco-jcc/jjaf022

Related content

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Association between estimated plasma volume status and the risk of 30-day mortality in patients with severe acute pancreatitis: a retrospective study based on the MIMIC-IV database

Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study

Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study

Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis

Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study

Non-Conventional Dysplasia in Patients with Inflammatory Bowel Disease and Colorectal Adenocarcinoma: A Case-Cohort Study